The winner of this week's presidential contest, regardless of the outcome, will be faced next year with the challenge of leading agencies whose reputations have suffered badly during the pandemic under the direction of President Donald Trump.
Guy with an MPH. Formerly a health reporter at CQ Roll Call. Still not a very active Twitter user!
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Andrew Siddons
Trump vs. Biden: 'Rounding the corner' or 'dark winter' on virus
With Election Day edging closer, President Donald Trump and Democratic challenger Joe Biden have sharply contrasting views about the current severity of the COVID-19 pandemic and how they would shape health care over the next four years if elected. Those differences were on display during their final face-to-face debate on Thursday, which covered little new ground but presented their positions more clearly than their first debate, where substance was lost amid constant interruptions and attacks.
COVID-19 trials risk excluding those most vulnerable to virus Original
The elderly and communities of color have suffered disproportionately from the COVID-19 pandemic — and those groups are also at risk of being short-changed by fast-paced clinical trials with participants that skew younger and whiter than the general U.S. population. Older adults may be willing to participate in research but may not be appealing candidates to drug companies, due to their poorer underlying health.
Despite debate talk, Biden virus approach differs from Trump’s
By Sandhya Raman and Andrew Siddons Posted October 8, 2020 at 5:40pm Former Vice President Joe Biden’s plan for addressing the COVID-19 pandemic has much in common with what the Trump administration has attempted so far, but Biden’s overall approach would likely differ from Trump’s in important ways, experts say. Both campaigns emphasize access to testing, developing vaccines and making more medical supplies in the United States.
Unanswered COVID questions mark debate between Pence, Harris
Pence, Harris have civil debate, but do not answer questions on COVID and other topics Pence dodges on banning abortion, Harris on packing court Vice President Mike Pence and Democratic vice presidential nominee Sen. Kamala Harris had their only debate Tuesday at the University of Utah in Salt Lake City.
FDA rejects White House pressure for lower coronavirus vaccine standards
The Food and Drug Administration issued long-awaited guidance Tuesday on the data it expects from drug companies seeking emergency authorization of COVID-19 vaccines, rejecting White House pressure for lower standards intended to push out vaccines quickly. The 18-page guidance was released a day after reports suggested the White House had blocked the agency from issuing the guidelines, which are meant to engender public confidence.
Drug companies take advantage of lack of U.S. price limits
Internal documents show drugmakers’ reliance on US price hikes Drug company executives' bonus pay tied to price increases Chairwoman Carolyn Maloney, D-N.Y., presides during a House Oversight and Reform Committee hearing in August.
Flu could strain health system already burdened by COVID-19
A rough flu season could compound the problems the COVID-19 pandemic has already caused in the United States, and public health experts are warning that a mild flu season in the Southern hemisphere may not mean Americans will experience the same thing. The U.S. hasn’t been as aggressive in maintaining steps to mitigate the spread of the coronavirus, which had the bonus effect of limiting the spread of flu in the countries that did.
CDC chief seeks billions for vaccines, says millions went into ad campaign
CDC director seeks billions for vaccines, says millions were transferred for HHS ad campaign Redfield tells Senate panel $6 billion more is needed to help states and cities develop distribution plans; $250 million reportedly being used for public relations push The head of the Centers for Disease Control and Prevention asked senators Wednesday for billions of dollars more for COVID-19 vaccine distribution as he addressed allegations of political interference and disclosed that the Trump...
FDA to review huge applications from vaping companies
Wednesday’s long-delayed deadline for e-cigarette companies to seek permission from the Food and Drug Administration to keep selling their products is launching a new era of uncertainty for the industry and a slog for regulators facing applications that can exceed 100,000 pages.
Trump assertions of lower drug costs mask truth for many consumers Original
President Donald Trump campaigns on the message that he’s done more to lower drug prices than any other president, but the reality is more complicated. The administration contends that drug prices are rising at a slower pace after years of hikes, while research supports the idea that increases for brand-name drugs have moderated. But that doesn’t tell the full story. The most significant proposals in Congress to drive down prices stalled because of partisan differences and industry opposition.
Drug price spikes still unchecked, five years after controversy Original
The current debate over expensive prescription drugs caught fire after a notorious 2015 episode, when the price of a cheap, lifesaving drug was jacked up by more than 5,000 percent and the pharmaceutical executive behind it seemed to revel in the outrage over his decision. The drug was Daraprim, used to treat a parasitic infection, toxoplasmosis, that can be fatal, particularly in immunocompromised patients like those with HIV/AIDS or pregnant women.
Progressives eye ‘sea change’ at powerful House committee
There’s more than just another upset on the line in the expensive primary fight between Rep. Richard E. Neal, D-Mass., who’s represented the 1st Congressional District of Massachusetts since 1989, and Alex Morse, the 31-year-old mayor of Holyoke. A Morse victory would arguably be the most significant primary dethroning of a powerful House lawmaker since Majority Leader Eric Cantor, R-Va., was toppled in 2014.
Top health official argues against widespread COVID-19 testing approach
WASHINGTON — The Trump administration official overseeing the nationwide strategy for COVID-19 diagnostic testing is pushing back on the idea that more widespread and frequent testing of asymptomatic individuals is needed, arguing that focusing on the sick and vulnerable is already leading to an improvement in caseloads.
Top health official argues against more widespread COVID-19 testing
Top health official argues against widespread COVID-19 testing approach Some public health experts back more ubiquitous testing, while others are concerned the approach has limitations Cars line up at a COVID-19 test site at Dodger Stadium in Los Angeles on Wednesday.
Health official argues against widespread COVID testing
WASHINGTON — The Trump administration official overseeing the nationwide strategy for COVID-19 diagnostic testing is pushing back on the idea that more widespread and frequent testing of asymptomatic individuals is needed, arguing that focusing on the sick and vulnerable is already leading to an improvement in caseloads.
‘Exponential’ explosion of COVID-19 cases could be coming
Football games, protests, political rallies and going back to school: a confluence of mass public gatherings as the summer comes to a close could lead to the increased spread of COVID-19. “This is not going to be a linear explosion of disease,” said Georges Benjamin, executive director of the American Public Health Association and a former Maryland health secretary.
Events in coming weeks, months could cause new surge in coronavirus cases
A confluence of potential events in the coming weeks and months could exacerbate the spread of coronavirus infections following the summer surge, public health experts warn. Some football programs might allow thousands of fans to attend games in massive stadiums. In Washington, D.C., people from across the country will likely attend a demonstration commemorating the original March on Washington and cap off a summer of protests for racial justice.
COVID-19 vaccine trial could have results by November, Fauci says
Health officials: Results from COVID-19 vaccine trial may be ready by November Fauci said the goal is for the vaccine to reduce the risk of coronavirus infection by 60 percent Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, testified at a Senate Health, Education, Labor and Pensions Committee hearing on the COVID-19 pandemic.
Self-swab coronavirus tests face regulatory and logistic issues
Companies are hoping to sell self-administered COVID-19 tests to capitalize on the intense diagnostic demand, but the Food and Drug Administration is poised to crack down on companies marketing the tests, which already were facing questions about accuracy, logistics and costs. A handful of companies say they are already offering, or plan to launch, kits that allow people to use nasal swabs on themselves and then ship the sample to labs to process the tests.
Health care industry scrambles for funding in third coronavirus bill
WASHINGTON — The $1 trillion COVID-19 Senate GOP stimulus bill is filled with provisions the health care industry has long desired and could help bolster the response to the pandemic, but it also contains loosely related health care measures that members have struggled to advance in a divided Congress where little legislating has been accomplished. The bill would increase funding for hospitals, but Senate Minority Leader Charles E.
Health care industry scrambles for funding in third coronavirus bill
WASHINGTON — The $1 trillion COVID-19 Senate GOP stimulus bill is filled with provisions the health care industry has long desired and could help bolster the response to the pandemic, but it also contains loosely related health care measures that members have struggled to advance in a divided Congress where little legislating has been accomplished. The bill would increase funding for hospitals, but Senate Minority Leader Charles E.
Health industry scrambles for funding in third coronavirus bill
By Emily Kopp, Sandhya Raman, Andrew Siddons, and Lauren Clason Posted March 20, 2020 at 3:47pm The $1 trillion COVID-19 Senate GOP stimulus bill is filled with provisions the health care industry has long desired and could help bolster the response to the pandemic, but it also contains loosely related health care measures that members have struggled to advance in a divided Congress where little legislating has been accomplished.
FDA walks back Trump claims on COVID-19 drugs
By Andrew Siddons and Emily Kopp Posted March 19, 2020 at 3:42pm The Food and Drug Administration will pull out all the stops when it comes to approving treatments for COVID-19, President Donald Trump said Thursday, but it is unclear what policy changes are being pursued outside of the agency’s existing procedures.
Shortage of supplies for virus leads Trump to invoke war powers
Concerns about the need for domestic supplies to test and treat patients for COVID-19 led President Donald Trump on Wednesday to take the rare step of invoking the nation’s war powers authority. The Defense Production Act of 1950 gives the president broad powers to require manufacturers to boost production of critical supplies and equipment, including personal protective equipment, ventilators and respirator masks.
Bracing for coronavirus, hospitals call for more funding
By Mary Ellen McIntire and Andrew Siddons Posted March 16, 2020 at 5:21pm Hospitals are seeking more funding as they brace for more patients with COVID-19 infections and potential shortages of workers and supplies. Groups representing hospitals, doctors, and nurses are seeking an extra $1 billion to help build up temporary hospital capacity, protect workers and deal with other problems tied to the coronavirus pandemic.
Lab capacity increasing but barriers remain for COVID-19 tests
Lab capacity increasing but barriers remain for COVID-19 tests Roadblocks like shortages of routine supplies could impede progress An Architect of the Capitol employee uses a disinfectant wipe on a door in the Cannon Building to combat the spread of the coronavirus outbreak on March 12, 2020.
Coronavirus outbreak urgency may intersect with broader health bill effort
Coronavirus response needs could play a role in broader health care legislation that Congress is trying to pass by late May, former congressional staffers predicted at a CQ Roll Call event on Tuesday. Congress faces a May 22 deadline to extend funding for community health centers and expiring health care workforce training programs. That package of bills is being eyed for legislation to address surprise medical bills and drug prices, too.
Members left Trump coronavirus briefing frustrated
By Andrew Siddons, Emily Kopp, and Mary Ellen McIntire Posted March 5, 2020 at 4:30pm Trump administration health officials Thursday briefed House members on how they plan to ramp up testing to keep up with the rapidly spreading COVID-19 outbreak, but lawmakers are frustrated with the pace of testing availability and were emerging from frequent briefings with more questions than answers.
Vaping unboxed: Flavored products on the market despite FDA bans
Are you an old millennial who’s totally clueless about vapes? Well, in the wake of some recent and upcoming federal moves, former Rep. Duncan Hunter and Gen Z alike may have to forgo fruity flavored e-cigarettes forever. The House passed a bill last week limiting the sale of flavored vape products, and all e-cigarette companies must submit applications to the FDA by May for a chance to stay in operation.
Stronger cigarette warnings likely to renew legal challenges
WASHINGTON - By mid-March, the Food and Drug Administration is expected to require cigarette packs to carry stark images depicting the health consequences of smoking, but legal challenges are likely to slow the rule from taking effect more than a decade after Congress first called for it. The tobacco industry is likely to challenge the rule in court by pointing to the First Amendment, say lawyers following the rule-making.
US House passes bill to restrict flavored tobacco products
WASHINGTON — The House on Friday passed a bill that would ban flavored tobacco products and impose taxes and sales restrictions on e-cigarettes. While the bill was mainly touted as part of House Democrats' efforts to limit youth e-cigarette use, the vote underscored concerns that the bill could discriminate against some tobacco users. The bill, which passed 213-195, would ban all flavored tobacco products, including menthol cigarettes and flavored cigars.
Stronger cigarette warnings likely to renew legal challenges
WASHINGTON — By mid-March, the Food and Drug Administration is expected to require cigarette packs to carry stark images depicting the health consequences of smoking, but legal challenges are likely to slow the rule from taking effect more than a decade after Congress first called for it. The tobacco industry is likely to challenge the rule in court by pointing to the First Amendment, say lawyers following the rule-making.
House passes bill to restrict flavored tobacco products
The House on Friday passed, 213-195, a bill that would ban flavored tobacco products and impose taxes and sales restrictions on e-cigarettes. While the bill was mainly touted as part of House Democrats’ efforts to limit youth e-cigarette use, the vote underscored concerns that the bill could discriminate against some tobacco users. The bill would ban all flavored tobacco products, including menthol cigarettes and flavored cigars.
House passes bill to restrict flavored tobacco products
WASHINGTON - The House on Friday passed a bill that would ban flavored tobacco products and impose taxes and sales restrictions on e-cigarettes. While the bill was mainly touted as part of House Democrats' efforts to limit youth e-cigarette use, the vote underscored concerns that the bill could discriminate against some tobacco users. The bill, which passed 213-195, would ban all flavored tobacco products, including menthol cigarettes and flavored cigars.
Las advertencias de cigarrillos más firmes probablemente renovarán las impugnaciones legales
WASHINGTON — Se espera que para mediados de marzo la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) exija que las cajetillas de cigarrillos lleven imágenes claras que describan las consecuencias para la salud del consumo de tabaco, pero es probable que las impugnaciones legales retrasen la entrada en vigor de la norma más de una década después de que el Congreso la pidiera por primera vez.
Las advertencias de cigarrillos más firmes probablemente renovarán las impugnaciones legales
WASHINGTON — Se espera que para mediados de marzo la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) exija que las cajetillas de cigarrillos lleven imágenes claras que describan las consecuencias para la salud del consumo de tabaco, pero es probable que las impugnaciones legales retrasen la entrada en vigor de la norma más de una década después de que el Congreso la pidiera por primera vez.
Las advertencias de cigarrillos más firmes probablemente renovarán las impugnaciones legales
WASHINGTON — Se espera que para mediados de marzo la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) exija que las cajetillas de cigarrillos lleven imágenes claras que describan las consecuencias para la salud del consumo de tabaco, pero es probable que las impugnaciones legales retrasen la entrada en vigor de la norma más de una década después de que el Congreso la pidiera por primera vez.
Menthol ban causes discrimination concerns
A bill to restrict tobacco flavors could have a closer vote margin Friday than House leaders would like amid frustration from Congressional Black Caucus members that the bill could lead to unintended consequences in black communities. Tobacco-state Democrats also argue the bill would limit choices for adults who choose to use a legal product.
Vaccine prices a flashpoint in coronavirus funding talks
By David Lerman and Andrew Siddons Posted February 27, 2020 at 1:38pm A push by Democratic leaders to ensure the availability of low-cost vaccines could complicate negotiations on an emergency funding bill to combat the deadly disease caused by a coronavirus. There is no vaccine yet to combat the COVID-19 disease that has spread around the globe from China. But lawmakers are eager to ensure that any future vaccine doesn’t become subject to price gouging that would deny people access to it.
Stronger cigarette warnings likely to renew legal challenges
WASHINGTON — By mid-March, the Food and Drug Administration is expected to require cigarette packs to carry stark images depicting the health consequences of smoking, but legal challenges are likely to slow the rule from taking effect more than a decade after Congress first called for it. The tobacco industry is likely to challenge the rule in court by pointing to the First Amendment, say lawyers following the rule-making.
Stronger cigarette warnings likely to renew legal challenges
WASHINGTON — By mid-March, the Food and Drug Administration is expected to require cigarette packs to carry stark images depicting the health consequences of smoking, but legal challenges are likely to slow the rule from taking effect more than a decade after Congress first called for it. The tobacco industry is likely to challenge the rule in court by pointing to the First Amendment, say lawyers following the rule-making.
Stronger cigarette warnings likely to renew legal challenges
WASHINGTON — By mid-March, the Food and Drug Administration is expected to require cigarette packs to carry stark images depicting the health consequences of smoking, but legal challenges are likely to slow the rule from taking effect more than a decade after Congress first called for it. The tobacco industry is likely to challenge the rule in court by pointing to the First Amendment, say lawyers following the rule-making.
Stronger cigarette warnings likely to renew legal challenges
By mid-March, the Food and Drug Administration is expected to require cigarette packs to carry stark images depicting the health consequences of smoking, but legal challenges are likely to slow the rule from taking effect more than a decade after Congress first called for it. The tobacco industry is likely to challenge the rule in court by pointing to the First Amendment, say lawyers following the rule-making.
White House seeks $1.25 billion more for coronavirus response
The Trump administration sent a request to Congress on Monday night for $1.25 billion in additional emergency funding to help combat the deadly coronavirus disease outbreak. Combined with a move to allow the use of $535 million in previously appropriated funds for the Ebola virus response, among other unspent resources, the White House said the new plan would provide at least $2.5 billion to try to contain the COVID-19 disease.
Coronavirus outbreak helps lawmakers make case on drug shortage bills
WASHINGTON - The coronavirus outbreak is prompting fears of drug shortages in the United States because of how deeply the pharmaceutical supply chain relies on China. For lawmakers who were already working on bills to address shortages and bring more drug manufacturing back to the U.S., the epidemic is helping them prove their point. No drug manufacturers had notified the Food and Drug Administration about any risks to their supply chains as of earlier this month.
Coronavirus outbreak helps lawmakers make case on drug shortage bills
WASHINGTON — The coronavirus outbreak is prompting fears of drug shortages in the United States because of how deeply the pharmaceutical supply chain relies on China. For lawmakers who were already working on bills to address shortages and bring more drug manufacturing back to the U.S., the epidemic is helping them prove their point. No drug manufacturers had notified the Food and Drug Administration about any risks to their supply chains as of earlier this month.
Coronavirus outbreak helps lawmakers make case on drug shortage bills
WASHINGTON — The coronavirus outbreak is prompting fears of drug shortages in the United States because of how deeply the pharmaceutical supply chain relies on China. For lawmakers who were already working on bills to address shortages and bring more drug manufacturing back to the U.S., the epidemic is helping them prove their point. No drug manufacturers had notified the Food and Drug Administration about any risks to their supply chains as of earlier this month.
Coronavirus outbreak helps lawmakers make case on drug shortage bills
WASHINGTON — The coronavirus outbreak is prompting fears of drug shortages in the United States because of how deeply the pharmaceutical supply chain relies on China. For lawmakers who were already working on bills to address shortages and bring more drug manufacturing back to the U.S., the epidemic is helping them prove their point. No drug manufacturers had notified the Food and Drug Administration about any risks to their supply chains as of earlier this month.
Coronavirus outbreak helps lawmakers make case on drug shortage bills
The coronavirus outbreak is prompting fears of drug shortages in the United States because of how deeply the pharmaceutical supply chain relies on China. For lawmakers who were already working on bills to address shortages and bring more drug manufacturing back to the U.S., the epidemic is helping them prove their point.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Andrew
Contact Andrew, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack